ARCHIVES

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | March 1, 1974

Download PDF Visit The Full Archive

Related Articles

As Avastin Decision Nears, Patient Groups Split On PFS In Front Line Breast Cancer.

February 22, 2008

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

Cancer Congress Scientific Program To Update Basic, Clinical Science

April 2, 1982